RFP
KRYS icon

Root Financial Partners’s Krystal Biotech KRYS Stock Holding History

Root Financial Partners’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-17
Closed -$4.39K – 1914
2026
Q1 		$4.39K Buy
17
+10
+143% +$2.66K ﹤0.01% 1998
2025
Q4 		$1.73K Buy
+7
New +$1.47K ﹤0.01% 2011

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Root Financial Partners's KRYS Position: Q2 2026 in Review

Root Financial Partners sold out of Krystal Biotech (KRYS) in Q2 2026, closing a stake of 17 shares — an estimated $4.39K sold.

Root Financial Partners first reported a position in KRYS in Q4 2025 and held it in 2 quarters. The position peaked at $4.39K in Q1 2026. 423 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Root Financial Partners reported no remaining Krystal Biotech position as of Q2 2026 after selling out during the quarter.
  • Root Financial Partners sold 17 Krystal Biotech shares in Q2 2026, an estimated $4.39K.
  • Root Financial Partners first reported a position in Krystal Biotech in Q4 2025 and held it in 2 quarters.
  • Root Financial Partners's Krystal Biotech position peaked at $4.39K in Q1 2026.
  • 423 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.